[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1981

Oral Administration of Human Dialyzable Transfer Factor in a Patient With Psoriasis

Author Affiliations

Tucson, Ariz

Arch Dermatol. 1981;117(1):3-4. doi:10.1001/archderm.1981.01650010007009
Abstract

To the Editor.—  Psoriasis vulgaris is a common skin disorder that is often frustrating to treat. Although its cause is unclear, a defect in cell-mediated immunity has been postulated.1-3 This encouraged us to undertake treatment of a patient who had psoriasis with human transfer factor.

Report of a Case.—  A 55-year-old man had had psoriasis for more than 25 years. He first noted the disorder at age 24 years with the appearance of multiple intensely pruritic plaques about the size of quarters that spread during a two-month period to involve much of his scalp, elbows, knees, and other areas of the trunk and extremities. At that time, the only medication he was taking was morphine sulfate, employed to treat a World War II orthopedic injury. He denied the recent use of lithium carbonate. There was no family history of psoriasis.His psoriasis had been recalcitrant to treatment but had

First Page Preview View Large
First page PDF preview
First page PDF preview
×